Stakeholders Pour Out Approval Of Gottlieb’s Leadership At FDA

By David Roza / March 5, 2019 at 6:56 PM
Within hours of the announcement that FDA Commissioner Scott Gottlieb will be resigning from the agency in a month, an array of stakeholders sent out their near-universal applause of the commissioner’s leadership and policy initiatives. Though representatives of industry spoke fondly of the outgoing agency chief, Michael Carome, director of the Health Research Group at Public Citizen, condemned Gottlieb for his connections to the pharmaceutical industry, said his decisions at the agency favored industry over public health, and bid him...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.